Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

IRONWOOD PHARMACEUTICALS, INC. (IRWD)
Add to my list  
Mes dernières consult.
Most popular
Manage my lists
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Most relevant news about IRONWOOD PHARMACEUTICALS,
04/17IRONWOOD PHARMACEUTICALS : to Host First Quarter 2018 Investor Update Call
BU
04/11IRONWOOD PHARMACEUTICALS : Denner seeking Ironwood board seat
AQ
04/09IRONWOOD PHARMACEUTICALS : Announces Director Nomination from Sarissa Capital
PU
03/09IRONWOOD PHARMACEUTICALS : to Present at Upcoming March Investor Conferences
AQ
03/05IRONWOOD PHARMACEUTICALS : to Present at Upcoming March Investor Conferences
BU
03/01IRONWOOD PHARMACEUTICALS : Chief scientific officer of Ironwood Pharmaceuticals ..
AQ
02/19IRONWOOD PHARMACEUTICALS : Provides Fourth Quarter and Full Year 2017 Investor U..
AQ
02/15IRONWOOD PHARMACEUTICALS (NASDAQ : IRWD) reported earnings of ($0.14) per share ..
AQ
02/15IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
AQ
02/15IRONWOOD PHARMACEUTICALS : beats Street 4Q forecasts
AQ
02/15IRONWOOD PHARMACEUTICALS : Provides Fourth Quarter and Full Year 2017 Investor U..
BU
02/05IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter and Full-Year 2017 Investor Up..
AQ
02/01IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter and Full-Year 2017 Investor Up..
BU
01/30IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Costs Associated with ..
AQ
01/17Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS P..
AQ
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
04/17IRONWOOD PHARMACEUTICALS : to Host First Quarter 2018 Investor Update Call
BU
04/11IRONWOOD PHARMACEUTICALS : Denner seeking Ironwood board seat
AQ
04/09IRONWOOD PHARMACEUTICALS, INC (65IB) : 5/1/2018 to 4/30/2023
AQ
04/0965-- IRONWOOD PHARMACEUTICALS, INC ( : 5/1/2018 to 4/30/2023
AQ
04/09IRONWOOD PHARMACEUTICALS : Announces Director Nomination from Sarissa Capital
PU
03/15RHYTHM PHARMACEUTICALS : 6th Annual Chief Medical Officer Summit Announces the S..
AQ
03/09IRONWOOD PHARMACEUTICALS : to Present at Upcoming March Investor Conferences
AQ
03/05IRONWOOD PHARMACEUTICALS : to Present at Upcoming March Investor Conferences
BU
03/01IRONWOOD PHARMACEUTICALS : Chief scientific officer of Ironwood Pharmaceuticals ..
AQ
02/22IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/09Ironwood investor Sarissa Capital to nominate board member 
03/15Ironwood Pharmaceuticals (IRWD) Presents At Barclays Global Healthcare Confer.. 
03/12Ironwood Pharmaceuticals (IRWD) Presents At 38th Annual Cowen and Company Hea.. 
03/09Key events next week - healthcare (continued #5) 
03/09Key events next week - healthcare (continued #2) 
03/08Synergy Pharmaceuticals' Cash Flow And Prescription Trends 
Latest Tweets
04/20Berenberg Bank Begins Coverage on Ironwood Pharmaceuticals $IRWD  
04/20BREAKING: Toowoomba trainer Mark Currie has been suspended and charged with '.. 
04/19RECAP 4/19 +Pos Comments: $WTTR$ $CIB $IRWD $INVA $REPH $PBCT $NTEC $SYNT -Ne..
1
04/19$IRWD - Berenberg Bank Initiates Coverage on Ironwood Pharmaceuticals #IRWD  
04/19$IRWD initiated at Buy at Berenberg. PT $25 
More tweets
Qtime:96
Financials ($)
Sales 2018 378 M
EBIT 2018 -60,5 M
Net income 2018 -88,3 M
Debt 2018 283 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 7,64x
EV / Sales 2019 6,19x
Capitalization 2 607 M
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals, Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Technical analysis trends IRONWOOD PHARMACEUTICALS,
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 16,9 $
Spread / Average Target -2,1%
EPS Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
William I. Huyett Chief Operating Officer
Gina R. Consylman CFO, CAO, Controller & VP-Finance
Mark G. Currie Chief Scientific Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICALS, INC.15.28%2 607
CELLTRION, INC.--.--%31 467
IQVIA HOLDINGS INC-0.64%20 258
LONZA GROUP-6.95%18 703
INCYTE CORPORATION-27.09%14 493
NEKTAR THERAPEUTICS44.36%13 873
4-traders.com :
About :
Stay Connected :
Partners :
Copyright © 2018 Surperformance. All rights reserved.